Key Things You Should Know
Latest COVID-19 Articles
New Research Sheds Some Light On Long Covid
The Centers for Disease Control and Prevention (CDC) released a study last Tuesday that found one in five adults under 65 and one in four adults over 65 may develop long Covid. People in both groups had twice the risk of uninfected people of developing respiratory...
Kids 5 – 11 Approved to Get Booster as Case Numbers Rise
Last week, on May 17th, the Food and Drug Administration (FDA) authorized a booster shot for school-aged children. The approval is vital to making a third shot of Pfizer-BioNTech’s vaccine available to children between 5 – 11 years old. Two days later, the Centers for...
U.S. Reaches Grim Milestone as Officials Warn of Another Surge
According to the Centers for Disease Control and Prevention (CDC), the United States passed an inconceivable point in the Covid-19 pandemic this week—one million deaths. The news comes a little more than two years after the first death from the virus was recorded in...
FDA Limiting Use of J&J Vaccine Due to Blood Clot Risk
On May 5th, the Food and Drug Administration (FDA) placed new restrictions on the Johnson & Johnson coronavirus vaccine. The announcement comes as a result of the J&J vaccine being associated with a rare but potentially deadly blood clotting and bleeding...
Virus Mutations Continue as New Subvariants are Discovered
It’s been two and a half years since the novel coronavirus, SARS-CoV-2, first appeared in humans. During that time, it has mutated, creating variants and subvariants at a rate that has surprised scientists. And it shows no signs of slowing down. The main concern with...
Covid Deaths Rising in the Vaccinated
Throughout the pandemic, the unvaccinated have counted for most of the deaths. However, recent data indicates that is changing. The Centers for Disease Control and Prevention (CDC) released nationwide statistics showing vaccinated individuals made up 42% of the deaths...
Why is the Availability of Paxlovid Such a Big Deal?
Paxlovid is an antiviral medication made by Pfizer that decreases the chances of being hospitalized from Covid-19 by 90%. Merck also has an antiviral drug, Lagevrio, that is also effective at preventing hospitalizations from Covid. Clinical trials showed that Paxlovid...
To Mask, or Not to Mask?
Last week, in response to the rise in the BA.2 subvariant of the Omicron Covid-19 variant, the Centers for Disease Control and Prevention (CDC) extended the mask mandate for flying commercially and other public transit, like buses, subways, and ferries, through at...
New Omicron Subvariant Highly Transmissible But No Surge Yet
For the past several weeks, the Omicron BA.2 variant has become the new dominant strain of Covid-19 in the U.S. However, it hasn’t caused a major surge in cases so far despite doing so in other parts of the world, such as Europe. Public health experts are hopeful that...
Will the Next Vaccine be a Nasal Spray?
The speed of the development of the coronavirus vaccines and their effectiveness in keeping people alive and out of the hospital is nothing short of remarkable. The vaccines even showed significant levels of protection against several variants of Covid-19. Then came...